0 My Account

Estriol, the forgotten estrogen?

Follingstad AH, 1978

JAMA, 239(1), 29-30

Source

Abstract

No abstract available for this article.

Topics

Reproductive Endocrinology > Estrogen > PhysiologyPerimenopause/Menopause > HRT > AlternativesBone Health > Osteoporosis Risk > Prevention
estriol cancer risk, estriol versus estradiol safety, estriol breast cancer protection, forgotten estrogen estriol, estriol osteoporosis treatment, weak estrogen clinical applications, estriol hormone replacement therapy, estriol uterine cancer risk, estrogen metabolism estriol, selective estrogen effects estriol

Cite this article

Follingstad, A. H. (1978). Estriol, the forgotten estrogen?. *JAMA*, *239*(1), 29-30.

Keywords

Breast Neoplasms/chemically Induced, Estriol/adverse Effects/therapeutic Use, Female, Humans, Osteoporosis/drug Therapy, Risk, United States, United States Food and Drug Administration, Uterine Neoplasms/chemically Induced, Estriol,

Related articles

Chapter 33: Osteoporosis and Role of CrMS
Hilgers TW, 2004 The Medical and Surgical Practice of NaProTECHNOLOGY
Bone Health > Menstrual Cycle Effects > Ovulatory DisturbancesBone Health > Menstrual Cycle Effects > AmenorrheaBone Health > Progesterone > Bone Formation

Estriol in the management of the menopause
Tzingounis VA et al., 1978 JAMA

Estriol was administered for a six-month period as estrogen replacement therapy to 52 symptomatic postmenopausal women. Assays of serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), es...

Perimenopause/Menopause > HRT > AlternativesReproductive Endocrinology > Estrogen > Clinical EffectsPerimenopause/Menopause > Symptoms > Vasomotor